Abstract:123 While transplantation remains the only potentially useful treatment for end-stage organ failure, immunological rejection of allografts continues to be a major problem. We have investigated if the fate of T cell precursors developing in the thymus may be determined by the presence of allo MHC class I peptides, since T cell receptor-MHC class I / self peptide interaction regulates thymocyte development. This study examined the effects and underlying mechanisms of intrathymic (IT) injection of a short segment of a synthetic immunogenic MHC class I peptide [P-2; Residues 67 - 85] of the hypervariable domain of RT1.A derived from WAG rat [RT1u] on islet graft survival in the WF [RT1u]-to-ACI [RT1a]. The results showed that while IT injection of 150 µg P-2 on day -7 did not prolong graft survival in naive recipients [MST of 14.0 days vs 9.6 days in controls], IT injection of 300 µg or 600 µg P-2 led to normoglycemia and permanent islet survival [>200 days] in 4/6 and 3/5 STZ induced diabetic ACI recipients, respectively. IT injection of 150 µg, 300 µg, or 600 µg P-2 combined with 0.5 ml ALS immunosuppression on day -7 led to 100% permanent islet graft survival [>200 days] compared to MST of 15.0 ± 2.3 days in ALS alone treated controls. Similarly prepared animals rejected 3rd party [BN] islets in an acute fashion, thus demonstrating donor specificity. Intravenous injection of 300 µg P-2 combined with 0.5 ml ALS did not prolong islet allografts. The long-term unresponsive islet allograft recipients challenged with 2nd set grafts accepted permanently 4/4 donor-type cardiac allografts while rejecting 3rd party [Lewis] hearts without rejecting the primary [WF] islets. In analyzing the underlying mechanisms of acquired systemic tolerance, we found no suppresser / regulatory cells in the adoptive transfer studies in tolerant animals at 30 days after IT injection of allopeptides. In contrast, adoptive transfer of 5 × 107 unseparated spleen cells or 2 × 107 purified T-cells obtained from tolerant animals 60 and 120 days after islet transplantation into lightly irradiated [200 rad TBI] ACI led to donor-specific permanent islet graft survival in 75 and 100% animals respectively compared to an MST of 14.5 days in lightly irradiated ACI recipients of unmodified syngenic spleen cells. Our findings suggest that maintenance of acquired thymic tolerance induced by class I MHC allopeptides is dependent on generation of regulatory cells and that this strategy may have potential clinical application in the induction of acquired tolerance.

Adoptive Infusion of Tolerogenic Dendritic Cells Prolongs the Survival of Pancreatic Islet Allografts: A Systematic Review of 13 Mouse and Rat Studies

Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: an Overview of Systematic Reviews

Adoptive infusion of tolerance dendritic cells prolongs survival of small intestine allografts in rats: systematic review and meta-analysis.

Adoptive Transfusion of Tolerance Dendritic Cells Prolongs the Survival of Cardiac Allograft: a Systematic Review of 44 Basic Studies in Mice

Adoptive Transfusion of Tolerant Dendritic Cells Prolong the Survival of Renal Allografts: a Systematic Review

Adoptive transfusion of tolerance dendritic cells prolongs the survival of skin allografts in mice: a systematic review.

Adoptive transfusion of tolerogenic dendritic cells prolongs the survival of liver allograft: a systematic review.

Cotransplantation of Mesenchymal Stem Cells and Immature Dendritic Cells Potentiates the Blood Glucose Control of Islet Allografts

TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

Effective Induction of Immune Tolerance by Portal Venous Infusion with IL-10 Gene-Modified Immature Dendritic Cells Leading to Prolongation of Allograft Survival

SYNERGISTIC TOLERANCE BY ADOPTIVE TRANSFER OF TOLEROGENIC DENDRITIC CELLS AND T REGULATORY CELLS:

REGULATORY T CELLS MAINTAIN PERIPHERAL TOLERANCE TO ISLET ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF MHC CLASS I ALLOPEPTIDES

Tolerance induction to islet allografts

Role Of T And Dendritic Cells In Mouse Islet Allografts Treated With Anti-Cd45rb Monoclonal Antibodies

Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection Via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34+ Stem Cells-Reconstituted NOD-scid IL2rγnull Mice.

Immune Modulation of Co-Transplantation Mesenchymal Stem Cells with Islet on T and Dendritic Cells.

Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival.

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

Prevention of Allograft Rejection by in Vitro Generated Tolerogenic Dendritic Cells